CDH
GILD icon

Charles D. Hyman’s Gilead Sciences GILD Stock Holding History

Charles D. Hyman’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$376K Hold
5,476
– – 0.02% 182
2024
Q1 		$401K Sell
5,476
-100
-2% -$7.69K 0.02% 184
2023
Q4 		$452K Hold
5,576
– – 0.03% 171
2023
Q3 		$418K Sell
5,576
-325
-6% -$25K 0.03% 170
2023
Q2 		$455K Hold
5,901
– – 0.03% 171
2023
Q1 		$490K Hold
5,901
– – 0.03% 162
2022
Q4 		$507K Hold
5,901
– – 0.03% 154
2022
Q3 		$364K Hold
5,901
– – 0.03% 171
2022
Q2 		$365K Buy
5,901
+1,500
+34% +$92.9K 0.03% 174
2022
Q1 		$262K Hold
4,401
– – 0.02% 217
2021
Q4 		$320K Hold
4,401
– – 0.02% 203
2021
Q3 		$307K Hold
4,401
– – 0.02% 196
2021
Q2 		$303K Hold
4,401
– – 0.02% 202
2021
Q1 		$284K Hold
4,401
– – 0.02% 203
2020
Q4 		$256K Sell
4,401
-1,000
-19% -$60.3K 0.02% 207
2020
Q3 		$341K Sell
5,401
-35
-0.6% -$2.43K 0.03% 170
2020
Q2 		$418K Buy
5,436
+35
+0.6% +$2.68K 0.04% 149
2020
Q1 		$404K Sell
5,401
-82
-1% -$5.67K 0.05% 127
2019
Q4 		$356K Buy
5,483
+1,019
+23% +$66.4K 0.03% 152
2019
Q3 		$283K Hold
4,464
– – 0.03% 158
2019
Q2 		$302K Sell
4,464
-150
-3% -$9.87K 0.03% 155
2019
Q1 		$300K Buy
4,614
+450
+11% +$29.9K 0.03% 154
2018
Q4 		$260K Hold
4,164
– – 0.03% 144
2018
Q3 		$322K Sell
4,164
-74
-2% -$5.59K 0.03% 141
2018
Q2 		$300K Buy
4,238
+74
+2% +$5.23K 0.03% 142
2018
Q1 		$314K Hold
4,164
– – 0.04% 136
2017
Q4 		$298K Buy
4,164
+1,100
+36% +$83.5K 0.03% 133
2017
Q3 		$248K Hold
3,064
– – 0.03% 132
2017
Q2 		$217K Sell
3,064
-500
-14% -$33.3K 0.03% 137
2017
Q1 		$242K Buy
+3,564
New +$251K 0.03% 126

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Charles D. Hyman's GILD Position: Q2 2024 in Review

Charles D. Hyman held its Gilead Sciences (GILD) position steady in Q2 2024 at 5,476 shares worth $376K. The position accounts for 0.02% of the portfolio, ranked #182.

Charles D. Hyman first reported a position in GILD in Q1 2017 and has held it in 30 quarters since. The position peaked at $507K in Q4 2022. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

  • Charles D. Hyman held 5,476 shares of Gilead Sciences worth $376K as of Q2 2024.
  • Charles D. Hyman left its Gilead Sciences share count unchanged in Q2 2024.
  • Gilead Sciences made up 0.02% of Charles D. Hyman's portfolio in Q2 2024, its #182 holding.
  • Charles D. Hyman first reported a position in Gilead Sciences in Q1 2017 and has held it in 30 quarters since.
  • Charles D. Hyman's Gilead Sciences position peaked at $507K in Q4 2022.
  • 1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on Charles D. Hyman's 13F filing for Q2 2024, filed 25 Jul 2024.